Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03803488 · ClinicalTrials.gov registry record · NA
Simulated Clinical Use Testing on the DropSafe Safety Pen Needle
A NA study, sponsored by HTL-Strefa S.A..
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03803488: Completed NA study, sponsored by HTL-Strefa S.A..
NCT03803488 is a NA study that has completed, run by HTL-Strefa S.A.. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03803488, a NA study, has completed, sponsored by HTL-Strefa S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
A simulated clinical use testing on the DropSafe safety pen needle
Primary Outcome
The failure rate of the safety feature for the DropSafe safety pen needle was estimated using the proportion of devices that fail out of the total tested. Failure was defined as NSI or contact with the needle after injection or non-complete activation of the safety feature.
Interventions
- DEVICE DropSafe safety pen needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-09-28 |
| Est. Completion | 2016-12-09 |
| Phase | NA |
What the finished NCT03803488 record still lists
NCT03803488 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which DropSafe safety pen needle is the first listed.
NCT03803488 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03803488 about?
NCT03803488 is a clinical study titled "Simulated Clinical Use Testing on the DropSafe Safety Pen Needle". A simulated clinical use testing on the DropSafe safety pen needle
What is the current status of trial NCT03803488?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-09-28. Estimated completion is 2016-12-09.
What interventions are being tested in trial NCT03803488?
The interventions under investigation include: DropSafe safety pen needle (DEVICE).
Who is sponsoring clinical trial NCT03803488?
This trial is sponsored by HTL-Strefa S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03803488's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI